Interpharm Holdings Stock Forecast - Simple Regression

IPAH Stock  USD 0  0.00  0.00%   
The Simple Regression forecasted value of Interpharm Holdings on the next trading day is expected to be 0 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Interpharm Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Interpharm Holdings' historical fundamentals, such as revenue growth or operating cash flow patterns.
The Interpharm Holdings' current Receivables Turnover is estimated to increase to 10.47, while Inventory Turnover is projected to decrease to 3.41. . The Interpharm Holdings' current Net Loss is estimated to increase to about (14.4 M).
Simple Regression model is a single variable regression model that attempts to put a straight line through Interpharm Holdings price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Interpharm Holdings Simple Regression Price Forecast For the 28th of December

Given 90 days horizon, the Simple Regression forecasted value of Interpharm Holdings on the next trading day is expected to be 0 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Interpharm Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Interpharm Holdings' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Interpharm Holdings Stock Forecast Pattern

Backtest Interpharm HoldingsInterpharm Holdings Price PredictionBuy or Sell Advice 

Interpharm Holdings Forecasted Value

In the context of forecasting Interpharm Holdings' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Interpharm Holdings' downside and upside margins for the forecasting period are 0 and 0, respectively. We have considered Interpharm Holdings' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0
0
Expected Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Interpharm Holdings stock data series using in forecasting. Note that when a statistical model is used to represent Interpharm Holdings stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria38.7167
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Interpharm Holdings historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Interpharm Holdings

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Interpharm Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.0000.00
Details
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Interpharm Holdings. Your research has to be compared to or analyzed against Interpharm Holdings' peers to derive any actionable benefits. When done correctly, Interpharm Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Interpharm Holdings.

Other Forecasting Options for Interpharm Holdings

For every potential investor in Interpharm, whether a beginner or expert, Interpharm Holdings' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Interpharm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Interpharm. Basic forecasting techniques help filter out the noise by identifying Interpharm Holdings' price trends.

Interpharm Holdings Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Interpharm Holdings stock to make a market-neutral strategy. Peer analysis of Interpharm Holdings could also be used in its relative valuation, which is a method of valuing Interpharm Holdings by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Interpharm Holdings Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Interpharm Holdings' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Interpharm Holdings' current price.

Interpharm Holdings Market Strength Events

Market strength indicators help investors to evaluate how Interpharm Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Interpharm Holdings shares will generate the highest return on investment. By undertsting and applying Interpharm Holdings stock market strength indicators, traders can identify Interpharm Holdings entry and exit signals to maximize returns.

Currently Active Assets on Macroaxis

When determining whether Interpharm Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Interpharm Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Interpharm Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Interpharm Holdings Stock:
Check out Historical Fundamental Analysis of Interpharm Holdings to cross-verify your projections.
For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Interpharm Holdings. If investors know Interpharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Interpharm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.09)
Revenue Per Share
1.048
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.19)
Return On Equity
(1.17)
The market value of Interpharm Holdings is measured differently than its book value, which is the value of Interpharm that is recorded on the company's balance sheet. Investors also form their own opinion of Interpharm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Interpharm Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Interpharm Holdings' market value can be influenced by many factors that don't directly affect Interpharm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Interpharm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Interpharm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpharm Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.